Approaches to nicotine addiction treatment taking into account the neurobiological aspects of pathogenesis. Literature review

Aim. To analyze modern studies on most effective therapeutic approaches to the treatment of nicotine addiction by generalizing data on promising methods and strategies for their use.

Material and methods. The data from studies was generalized, in which the neurobiological pathogenesis of nicotine addiction and possible ways to solve this problem were analyzed. The search was carried out using the following keywords: "nicotine", "vaping", "epigenetics", "nicotine addiction", "nicotine replacement therapy", "electronic nicotine delivery systems" in the titles of publications, abstracts, keywords of articles in journals published in the period from January 1 2020 to October 1, 2024 and posted in following electronic bibliographic databases: PubMed, Сochrane Library, eLIBRARY. At the second stage, the received publications were evaluated according to the inclusion and exclusion criteria. At the final stage, a detailed study of the found publications in the compiled sample was carried out for new mechanisms of nicotine addiction formation and possible treatment methods.

Results. In publications posted and summarized in the above electronic bibliographic databases, special attention is paid to the molecular genetic mechanisms leading to neural adaptation and disease development. A new possible way to solve the problem is proposed — non-invasive brain stimulation.

Conclusion. The factual data on the pathogenesis of nicotine addiction are summarized, indicating that the participation of molecular genetic mechanisms in nicotine addiction is currently being actively discussed. Special attention is paid to neuroadaptation. Additional research is needed to analyze novel therapeutic tactics that involve non-invasive brain stimulation.

1. WHO Tobacco Dashboard [Internet]. July 31, 2023. Accessed October 22, 2024. https://www.who.int/ru/news-room/fact-sheets/detail/tobacco

2. Bauer-Kemény C, Herth FJF. Rauchen – Noxen und immunologische Folgen. Radiologie (Heidelb). 2022; 62(9):731-737. https://doi.org/10.1007/s00117-022-01006-6

3. Peiffer G, Perriot J, Underner M et al. Sevrage tabagique du patient atteint de BPCO : importance de l’éducation thérapeutique. Rev Mal Respir. 2023;40(6):520-530. https://doi.org/10.1016/j.rmr.2023.03.008

4. Larsson SC, Burgess S. Appraising the causal role of smoking in multiple diseases: A systematic review and meta-analysis of Mendelian randomization studies. EBioMedicine. 2022;82:104-154. https://doi.org/10.1016/j.ebiom.2022.104154

5. Serrano Gotarredona MP, Navarro Herrero S, Gómez Izquierdo L et al. Smoking-related interstitial lung disease. Radiologia. 2022;64(3):277-289. https://doi.org/10.1016/j.rxeng.2022.10.008

6. Sansone L, Milani F, Fabrizi R et al. Nicotine: From Discovery to Biological Effects. International Journal of Molecular Sciences. 2023;24(19):14570. https://doi.org/10.3390/ijms241914570

7. Reitsma M.B., Kendrick P.J., Ababneh E. et al. Spatial, Temporal, and Demographic Patterns in Prevalence of Smoking Tobacco Use and Attributable Disease Burden in 204 Countries and Territories, 1990–2019: A Systematic Analysis from the Global Burden of Disease Study 2019. Lancet. 2021;397:2337–2360. https://doi.org/10.1002/dmrr.3572/v2/review2

8. Hall B.J., Wells C., Allenby C.et al. Differential Effects of Non-Nicotine Tobacco Constituent Compounds on Nicotine Self-Administration in Rats. Pharmacology Biochemistry and Behavior. 2014;120:103–108. https://doi.org/10.1016/j.pbb.2014.02.011

9. Bravo-Gutiérrez OA, Falfán-Valencia R, Ramírez-Venegas A. et al. Lung Damage Caused by Heated Tobacco Products and Electronic Nicotine Delivery Systems: A Systematic Review. International Journal of Environmental Research and Public Health. 2021;18(8):4079. https://doi.org/10.3390/ijerph18084079

10. Tituana NY, Clavijo CG, Espinoza EF et al. E-cigarette use-associated lung injury (EVALI). Pneumologie. 2024;78(1):58-69. https://doi.org/10.1055/a-2161-0105

11. Neczypor EW, Mears MJ, Ghosh A. et al. E-Cigarettes and Cardiopulmonary Health: Review for Clinicians. Circulation. 2022;145(3):219-232. https://doi.org/10.1161/circulationaha.121.056777

12. Banks E, Yazidjoglou A, Brown S. et al. Electronic cigarettes and health outcomes: umbrella and systematic review of the global evidence. Medical Journal of Australia. 2023;218(6):267-275. https://doi.org/10.5694/mja2.51890

13. N.D. Volkow, G.F. Koob, A.T. McLellan. Neurobiological advances from the brain disease model of addiction. New England Journal of Medicine, 2016;374:363-371. https://doi.org/10.1056/nejmra1511480

14. Y. Rabat, S. Chanraud, M. Abdallah et al. Precision preventive medicine of relapse in smoking cessation: can MRI inform the search of intermediate phenotypes? Biology, 2021;11:35. https://doi.org/10.3390/biology11010035

15. Benowitz NL. Nicotine addiction. New England Journal of Medicine. 2010;362:2295–2303. http://doi.org/10.1056/NEJMra0809890

16. Esteban Ronda V, Pastor Esplá E, Rábade Castedo C. Functional Brain Imaging in the Treatment of Nicotine Dependence. Archivos de Bronconeumología. 2023;59(9):543-545. https://doi.org/10.1016/j.arbres.2023.01.011

17. Picciotto MR, Kenny PJ. Mechanisms of Nicotine Addiction. Cold Spring Harbor Perspectives in Medicine. 2021;11(5):a039610. https://doi.org/10.1101/cshperspect.a039610

18. Caspar Muenstermann, Kelly J. Clemens, Epigenetic mechanisms of nicotine dependence. Neuroscience & Biobehavioral Reviews. 2024;156:a105505. https://doi.org/10.1016/j.neubiorev.2023.105505

19. Antonella Pisera-Fuster, Maria Paula Faillace, Ramon Bernabeu. Pre-exposure to nicotine with nocturnal abstinence induces epigenetic changes that potentiate nicotine preference. Molecular Neurobiology. 2020;57:1828-1846. https://doi.org/10.1007/s12035-019-01843-y

20. N.A. Youngson, M.R. Castino, A. Stuart et al. A role for a novel natural antisense-BDNF in the maintenance of nicotine-seeking. Addiction Neuroscience. 2022;2, a100010 https://doi.org/10.1016/j.addicn.2022.100010

21. Antonella Pisera-Fuster, Jean Zwiller, Ramon Bernabeu. Methionine supplementation abolishes nicotine-induced place preference in zebrafish: a behavioral and molecular analysis. Molecular Neurobiology. 2021;58(6):2590-2607. https://doi.org/10.1007/s12035-020-02260-2

22. Gould T.J. Epigenetic and Long-Term Effects of Nicotine on Biology, Behavior, and Health. Pharmacological Research. 2023;192:a106741. https://doi.org/10.1016/j.phrs.2023.106741

23. Hajiasgharzadeh K., Naghipour B., Shahabi P. et al. The role of microRNAs in nicotine signaling. EXCLI Journal. 2023;22:433–450. https://doi.org/10.17179/excli2023-6096

24. Bulygin KV, Beeraka NM, Saitgareeva AR et al. Can miRNAs Be Considered as Diagnostic and Therapeutic Molecules in Ischemic Stroke Pathogenesis?-Current Status. International Journal of Molecular Sciences. 2020;21(18):a6728. https://doi.org/10.3390/ijms21186728

25. Substance Abuse and Mental Health Services Administration (US); Office of the Surgeon General (US). Facing Addiction in America: The Surgeon General's Report on Alcohol, Drugs, and Health [Internet]. Nov, 2016. Accessed October 22, 2024 https://www.ncbi.nlm.nih.gov/books/NBK424857/

26. Rigotti NA, Kruse GR, Livingstone-Banks J. et al. Treatment of Tobacco Smoking: A Review. JAMA. 2022;327(6):566-577. https://doi.org/10.1001/jama.2022.0395

27. Sazonova M. S., Nesterova O. V., Biryukova N. V. Metody izbavleniya ot tabachnoj zavisimosti// Tendencii razvitiya nauki i obrazovaniya. 2021;74(1): 109-111. https://doi.org/10.18411/lj-06-2021-24

28. Baranova L.M., Primenenie metodov kognitivno-povedencheskoj psihoterapii i psihicheskoj samoregulyacii pri lechenii pacientov s tabakokureniem. Zdorov'e. Medicinskaya ekologiya. Nauka. 2016;1:52-54

29. Sandhu A, Hosseini SA, Saadabadi A. Nicotine Replacement Therapy. StatPearls [Internet]. Nov 12, 2023. Accessed October 22, 2024. https://www.ncbi.nlm.nih.gov/books/NBK493148/

30. Patel AR, Panchal JR, Desai CK. Efficacy of varenicline versus bupropion for smoking cessation: A systematic review and meta-analysis of randomized controlled trials. Indian Journal of Psychiatry. 2023;65(5):526-533.

31. https://doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_218_22

32. Shang X, Fenfen E, Guo K et al. Effectiveness and Safety of Varenicline for Smoking Cessation: An Overview and Meta-analysis. Journal of Addiction Medicine. 2023;17(5):536-543. https://doi.org/10.1097/adm.0000000000001171

33. Singh D, Saadabadi A. Varenicline. StatPearls [Internet]. Oct 5, 2024. Accessed October 22, 2024..

34. Courtney RJ, McRobbie H, Tutka P. et al. Effect of Cytisine vs Varenicline on Smoking Cessation: A Randomized Clinical Trial. JAMA. 2021;326(1):56-64. https://doi.org/10.1001/jama.2021.16064

35. Rigotti NA, Benowitz NL, Prochaska J. et al. Cytisinicline for Smoking Cessation: A Randomized Clinical Trial. JAMA. 2023;330(2):152-160. https://doi.org/10.1001/jama.2023.10042

36. L. Dinur-Kelin, P. Dannon, A. Hadar et al. Smoking cessation induced by deep repetitive transcranial magnetic stimulation of the prefrontal and insular cortices: a prospective, randomized controlled trial. Biological Psychiatry. 2014;76: 742-749 https://doi.org/10.1016/j.biopsych.2014.05.020

37. M. Mondino, D. Luck, S. Grot et al. Effects of repeated transcranial direct current stimulation on smoking, craving and brain reactivity to smoking cues. Scientific Reports, 2018;8:8724 https://doi.org/10.1038/s41598-018-27057-1

38. B. Petit, A. Dornier, V. Meille et al. Non-invasive brain stimulation for smoking cessation: a systematic review and meta-analysis. Addiction, 2022;117: 2768-2779 https://doi.org/10.1111/add.15889

39. P.T. Tseng, J.S. Jeng, B.S. Zeng et al. Efficacy of non-invasive brain stimulation interventions in reducing smoking frequency in patients with nicotine dependence: a systematic review and network meta-analysis of randomized controlled trials. Addiction, 2022;117:1830-1842. https://doi.org/10.1111/add.15624

40.